Transposagen Biophamaceuticals Overview
Transposagen Biophamaceuticals General Information
Description
Developer of animal models, cell lines, stem cells, research tools and technologies to improve drug discovery and development research. The company is biotechnology based and provides genetically modified rat models to pharmaceutical and biotechnology companies, academic laboratories and the National Institutes of Health.
Want to dig into this profile?
We’ll help you find what you need
Learn more
Transposagen Biophamaceuticals Valuation & Funding
| Deal Type |
Date |
Amount |
Raised to Date |
Post-Val |
Status |
Stage |
| 4. Grant |
21-Jun-2013 |
$4.3M |
00.000 |
|
Completed |
Generating Revenue |
| 3. Angel (individual) |
18-Jul-2012 |
00000 |
00.000 |
|
Completed |
Generating Revenue |
| 2. Angel (individual) |
20-Dec-2011 |
$725K |
$725K |
|
Completed |
Generating Revenue |
| 1. Accelerator/Incubator |
|
|
|
|
Completed |
Startup |
Transposagen Biophamaceuticals Competitors (11)
| Company Name |
Financing Status |
Location |
Employees |
Total Raised |
Last Financing Date/Type |
Last Financing
Amount |
| Caribou Biosciences |
Venture Capital-Backed |
Berkeley, CA |
00 |
000.00 |
00000000000 |
000.00 |
| 00000000 |
Venture Capital-Backed |
Redwood City, CA |
000 |
00000 |
00000000000 |
00000 |
| 0000000 |
Corporation |
Seoul, South Korea |
00 |
|
|
|
| 000000 00000000000 |
Formerly VC-backed |
Zug, Switzerland |
000 |
00000 |
00000000000 |
00000 |
| 000000000 |
Formerly VC-backed |
Piscataway Township, NJ |
0000 |
00000 |
00000000 |
00000 |
Transposagen Biophamaceuticals Executive Team (1)
| Name |
Title |
Board Seat |
Contact Info |
| Eric Ostertag Ph.D |
Chief Executive Officer & President |
|
|
Transposagen Biophamaceuticals Board Members (1)
| Name |
Representing |
Role |
Since |
| Nishan Silva MD |
Self |
Board Member |
000 0000
|